Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Gross Margin

GlaxoSmithKline CR`s Gross Margin reached 11.6 % in 2017. This is 2.19 % more than in the previous year.

$1.99

Buy Gross Margin data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...             41.9 37.0 33.9 26.6 26.3    
Bayer Czech Republic % ... ... ...                 0.050 11.5 13.1 12.3 13.8    
GlaxoSmithKline Czech Republic % ... ... ...                 10.7 12.4 11.5 12.3 11.4    
Merck Czech Republic % ... ...                   14.3 13.1 10.7 11.2 14.2    
Novartis Czech Republic %                       10.2 11.1 12.3 15.1 14.4    
Pfizer Czech Republic % ... ...                   11.1 9.20 9.29 9.61 9.96    
Roche Czech Republic % ... ... ...                 12.4 13.0 15.6 17.5 27.3   ...
Sanofi-Aventis Czech Republic % ... ... ... ...               7.61 7.95 9.26 7.93 10.5    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 55.0 47.7 43.3 30.2    
Walmark % ... ... ...                 71.2 70.1 68.8 72.6 15.8